Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 3Unknown 2Not yet recruiting 2Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Neoplasms 3Supportive Care 1Signs and Symptoms 1Sepsis 1Rectal Neoplasms 1Prostatic Neoplasms 1Polycystic Ovary Syndrome 1Peripheral Nervous System Diseases 1Pain 1Menstruation Disturbances 1Lymphoma 1Lung Neoplasms 1Insulin Resistance 1Hyperandrogenism 1Hot Flashes 1Facies 1Breast Neoplasms 1Anxiety Disorders 1Anatomic Stage I Breast Cancer AJCC v8 1Agnosia 1

Interventions

pembrolizumab 49Carboplatin 44Magnetic Resonance Spectroscopy 40Specimen Handling 39Pemetrexed 34Cisplatin 25Blood Specimen Collection 25durvalumab 17Paclitaxel 16osimertinib 15Radiotherapy 15Radiosurgery 15Bevacizumab 15Gemcitabine 14atezolizumab 13Nivolumab 13Biopsy 13Drug Therapy 12Standard of Care 10Practice Guidelines as Topic 10Immunoglobulin G 10Docetaxel 10130-nm albumin-bound paclitaxel 10X-Rays 9Taxes 9Educational Status 9Disulfides 9tislelizumab 8Etoposide 8Cetuximab 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Lung Neoplasms × Acupuncture Therapy × Clear all
NCT06926140 2025-07-24

Acupuncture Combined With PD-1/PD-L1 Inhibitors for Advanced Lung Cancer

Guang'anmen Hospital of China Academy of Chinese Medical Sciences

Phase NA Recruiting
240 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡